Gibson Dunn has advised Accenture plc and Accenture Capital Inc. Davis Polk has advised the joint book-running managers. Accenture plc (NYSE: ACN), a global professional services...
Accenture Completes $5 Billion SEC-Registered Senior Notes Offering
CRISPR Therapeutics Issues $600 Million Convertible Senior Notes
Walder Wyss has advised CRISPR Therapeutics. Davis Polk has advised the initial purchasers. CRISPR Therapeutics AG has successfully completed an offering of $600 million aggregate principal...
AGI Inc. Completes US$240 Million Initial Public Offering on NYSE
Davis Polk and Pinheiro Neto Advogados have advised AGI Inc. and White & Case and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados have advised...
Bristol Myers Squibb Completes €5 Billion Euro Senior Notes Offering and $7.5 Billion Tender Offer
Kirkland & Ellis has advised Bristol Myers Squibb. Davis Polk & Wardwell has advised the underwriters. Bristol Myers Squibb has completed its inaugural €5 billion public...
Cosan Completes R$10.5 Billion Follow-On Offering
Davis Polk has advised Cosan S.A. Skadden has advised BTG Pactual, Bradesco BBI, Santander, Itau BBA, J.P. Morgan and Citigroup. Cosan S.A. has finalized follow-on equity...